GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients

Pharmacogenomics, Ahead of Print.

Source: Future Medicine: Pharmacogenomics - March 17, 2019 Category: Genetics & Stem Cells Authors: Mingjun Yu Kaiyu Wang Haiming Liu Rui Cao Source Type: research